ENDO 2010 Annual Meeting - Includes 5 Complimentary Sessions
Click here to go to the previous page
CLINICAL - NIDDK Anniversary Symposium: The Sweetheart Controversy — Prevention & Treatment of Coronary Disease in Diabetes
Program Code:
S40
Date:
Sunday, June 20, 2010
Time:
3:45 PM to 5:15 PM
EST
SPEAKER
(S):
Robert E. Ratner, MD, MedStar Res Inst, Bethesda, MD
Disclosure: Nothing to Disclose
Saul Genuth, MD, Case Western Reserve Univ, Cleveland, OH
Disclosure: Owner, Johnson & Johnson, GlaxoSmithKline; Coinvestigator, Novartis Pharmaceuticals.
Patrick J. Boyle, MD, Univ of New Mexico, Albuquerque, NM
Disclosure: Speaker, Amylin Pharmaceuticals; Speaker Bureau Member, Lilly USA, LLC, Takeda.
No items are available for this session.